These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 6494246)

  • 21. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postmarketing surveillance of IUDs.
    Kessel E; Chi IC; Feldblum P
    Contracept Deliv Syst; 1983 Jan; 4(1):15-26. PubMed ID: 12264712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analgesia and anesthesia for neonates: study design and ethical issues.
    Anand KJ; Aranda JV; Berde CB; Buckman S; Capparelli EV; Carlo WA; Hummel P; Lantos J; Johnston CC; Lehr VT; Lynn AM; Maxwell LG; Oberlander TF; Raju TN; Soriano SG; Taddio A; Walco GA
    Clin Ther; 2005 Jun; 27(6):814-43. PubMed ID: 16117988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in adverse drug reactions in phase III and phase IV of the drug evaluation process.
    Linden M
    Psychopharmacol Bull; 1993; 29(1):51-6. PubMed ID: 8378512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance and challenges of studying marketed drugs: what is a phase IV study? Common clinical research designs, registries, and self-reporting systems.
    Glasser SP; Salas M; Delzell E
    J Clin Pharmacol; 2007 Sep; 47(9):1074-86. PubMed ID: 17766697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Issues in the design of clinical trials for safety in HIV-infected children.
    Lindsey JC; Kline MW
    Pediatr AIDS HIV Infect; 1996 Apr; 7(2):69-82. PubMed ID: 11361484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmarketing surveillance versus clinical trials: which benefits the patient?
    Lawson DH
    Cardiology; 1994; 85 Suppl 1():18-23. PubMed ID: 7743530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
    Hanley GE; Morgan S
    Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Difficulties with conducting clinical trials in France].
    Zannad F; Plétan Y
    Therapie; 2001; 56(4):341-7. PubMed ID: 11677850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmaceutical companies as sponsors of clinical trials--advantages and limitations].
    Reis LL
    Rev Port Cardiol; 1992 Apr; 11(4):333-8. PubMed ID: 1632988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials.
    Safer DJ
    J Nerv Ment Dis; 2002 Sep; 190(9):583-92. PubMed ID: 12357091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retrospective clinical analysis for drug rescue: for new indications or stratified patient groups.
    Cavalla D; Singal C
    Drug Discov Today; 2012 Feb; 17(3-4):104-9. PubMed ID: 22001144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The practice of pre-marketing safety assessment in drug development.
    Chuang-Stein C; Xia HA
    J Biopharm Stat; 2013; 23(1):3-25. PubMed ID: 23331218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The need for noninvasive biomarkers for drug safety in neonatal circulation.
    Rabe H
    Biomark Med; 2010 Oct; 4(5):771-6. PubMed ID: 20945992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japanese Physicians' Views on Drug Post-Marketing Surveillance.
    Maeda K; Katashima R; Ishizawa K; Yanagawa H
    J Clin Med Res; 2015 Dec; 7(12):956-60. PubMed ID: 26566409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Profile of clinical trials enrolling Brazilian children].
    Vieira JML; Lima EDC; Land MGP; Ventura M; Coelho HLL
    Cad Saude Publica; 2017 Jun; 33(5):e00169515. PubMed ID: 28614452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Directive principles for trials of cerebrally-acting drugs to be performed by groups of general practitioners].
    Hugonot L; Israël L; Hugonot R
    Presse Med; 1983 Dec; 12(48):3147-9. PubMed ID: 6228930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seeking Similarities Rather Than Differences With Adults to Aid in Therapeutic Advancement for Children.
    Becker ML; Kraft WK
    Clin Pharmacol Ther; 2021 Jul; 110(1):11-14. PubMed ID: 34148235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.